Chemicals · NSE: KRONOX
Intrynsic's multi-model valuation estimates Kronox Lab Sciences Limited's fair value at ₹171 per share (range ₹91–₹218) against a market price of ₹191 (close of 11 Nov 2026): the estimate is 10% below the price. Estimate updated 11 November 2026. This is an estimated fair value based on stated assumptions, not investment advice.
Market price
₹191
close of 11 Nov 2026
Est. fair value
₹171
₹91–₹218
Estimate vs price
-10.4%
estimate below price
Near fair-value est.
FY26
FY26
FY26
FY26
Over the last 3 years, revenue grew 1.7%/yr and profit grew 20.5%/yr. Over 6 years, revenue grew 12.4%/yr and profit 20.8%/yr.
Every ₹100 of shareholder money earned ₹24.1 in profit last year, vs a sector median of 8.2%.
It holds more cash than debt.
The market price is close to our estimated fair value (based on stated assumptions).
About ₹72 of every ₹100 of reported profit turned into free cash (median, last 5 years); operating cash flow was positive in 5 of 5 years.
Intrynsic's multi-model valuation estimates Kronox Lab Sciences Limited's fair value at ₹171 per share (range ₹91–₹218), last updated 11 November 2026. This is an estimate based on stated assumptions, not investment advice.
Kronox Lab Sciences Limited trades at ₹191 against Intrynsic's estimated fair value of ₹171 - the market price is 10% above the estimate, i.e. above our estimated fair-value range. Different assumptions produce different estimates; see the model breakdown above.
Kronox Lab Sciences Limited trades at about 25.6 times its latest annual earnings per share.
Intrynsic runs 3 valuation models for Kronox Lab Sciences Limited (DCF, EV/EBITDA, P/E Multiple) and blends them into one estimated fair-value range. Every assumption - growth, discount rate, terminal value - is shown openly on this page.
Kronox Lab Sciences Limited operates in the Chemicals sector (Chemicals & Petrochemicals industry) and is listed on the NSE as KRONOX.
Disclaimer: Intrynsic provides educational and informational analysis only. Fair-value figures are estimates based on stated assumptions- they are not investment advice, research recommendations, or an offer to transact in any security. The models rely on assumptions (discount rates, growth, multiples) that may prove wrong and on past financials, which do not guarantee future results; prices also move on macro factors the models don't capture. Intrynsic is not a SEBI-registered investment adviser or research analyst. Markets carry risk; please do your own research or consult a registered adviser before making investment decisions. Prices shown may be delayed end-of-day values. Terms · Privacy